Financial investor CVC initiates takeover of CompuGroup Medical SE & Co. KGaA

A&O Shearman has advised the supervisory board and the independent members of the administrative board of CompuGroup Medical SE & Co. KGaA (CGM) in connection with a strategic partnership agreement between CGM and CVC Capital Partners (CVC), a leading global private equity firm, and GT 1 Vermögensverwaltung GmbH, the majority shareholder of CGM.

In particular, the partnership with CVC will become effective if a bidder controlled by CVC investment funds successfully completes a voluntary public tender offer directed at all CGM shareholders at a price of EUR 22.00 per CGM share. The offer price corresponds to a premium of 51.1 per cent on the volume-weighted average price of the past three months.

The administrative board, the managing directors and the supervisory board welcome the strategic partnership with CVC and the voluntary public tender offer. The founding Gotthardt family and its related shareholder Dr. Reinhard Koop will retain their majority stake in CGM. CGM founder Frank Gotthardt remains chairman of the administrative board, and Prof. (apl.) Dr. med. Daniel Gotthardt continues as chief executive officer and member of the administrative board.

The partnership with CVC is expected to support CGM's long-term innovation and growth strategy. Together, CGM and CVC aim to drive innovation in healthcare for the benefit of patients and healthcare providers worldwide. The declared joint goal is to offer medical professionals reliable support with next-generation products and strong customer support.

CompuGroup Medical SE & Co. KGaA is one of the leading e-health companies in the world, generating revenues of EUR 1.19bn in 2023. With over 8,700 staff at locations in 19 countries, the company offers its products in 60 countries worldwide.

CVC is a leading global private markets manager with a network of 30 office locations throughout EMEA, the Americas and Asia, with approximately EUR 193bn of assets under management. Funds managed or advised in line with CVC's private equity strategy are invested in approximately 130 companies worldwide, which have combined annual sales of over EUR 155bn and employ more than 600.000 people.

The A&O Shearman team led by partner Dr. Christian Eichner (Düsseldorf) and senior associate Eva Hohmann (Corporate/M&A, Düsseldorf) further comprised partners Dr. Michael Weiß (Frankfurt, Corporate/M&A), Dr. Börries Ahrens (Antitrust, Hamburg), Thomas Neubaum (Banking and Finance) and Dr. Udo Olgemöller (Public Law, both Frankfurt), counsel Kyrill Chilevych (Düsseldorf), Dr. Andre Wandt (both Corporate/M&A) and Dr. Mark Hallett (Banking and Finance, both Frankfurt) as well as senior associates Dr. Stephan Bühner (Public Law, Frankfurt) and Dr. Kathrin Haag (Antitrust, Hamburg) and associates Dr. Christina Vossen, Dominic Herold, Robin Petschenka (all Corporate/M&A, all Düsseldorf), Dr. Katharina Hillmer (Antitrust, Hamburg) and Ann-Kathrin Ludwig (Banking and Finance, Frankfurt).